Navigation Links
PharmAthene Reports Year-End 2007 Financial Results

r 31, 2006 2,209 63

Additional paid-in capital 126,490,647 -

Accumulated other comprehensive income 1,481,779 63,954

Accumulated deficit (87,402,551) (69,851,819)

Total stockholders' equity (deficit) 40,572,084 (69,787,802)

Total liabilities, convertible redeemable

preferred stock, and stockholders'

equity (deficit) $66,611,132 $14,767,504



Year ended December 31,

2007 2006

Contract and grant revenue $14,624,595 $1,641,822

Other revenue 19,020 21,484

14,643,615 1,663,306

Operating expenses:

Research and development 16,559,670 7,259,359

General and administrative 13,882,023 8,453,941

Depreciation and amortization 705,370 483,646

Total operating expenses 31,147,063 16,196,946

Loss from operations (16,503,448) (14,533,640)

Other income (expense):

Interest income 1,122,565 289,606

Gain on extinguishment of debt 886,963 -

Interest expense (2,122,624) (538,948)

Change in market value of derivative

instruments 3,029,241 (350,405)

Total other income (expense) 2,916,145 (599,747)

Net loss (13,587,303) (

SOURCE PharmAthene, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
2. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
3. PharmAthene Named as Contractor in $13.9 Million Award Notice Published by the Department of Health and Human Services
4. Delaware Court Denies Motion by SIGA Technologies Seeking to Dismiss PharmAthenes Legal Action in Breach of Contract Lawsuit Against SIGA
5. PharmAthene to Present at the BIO CEO & Investor Conference 2008
6. PharmAthene Enhances Executive Leadership Team and Appoints Joan Fusco, Ph.D. Senior Vice President of Operations
7. PharmAthene Completes Pharmacokinetic Studies of Protexia(R); Program on Target for IND Filing in 2008
8. PharmAthene to Present at the Cowen and Company 28th Annual Health Care Conference
9. PharmAthene Signs Definitive Agreement to Acquire Biodefense Vaccines Business From Avecia
10. PharmAthene to Delay Release of Full Year 2007 Financial Results
11. PharmAthene Year-End 2007 Earnings Conference Call and Webcast Scheduled for Monday, March 31, 2008
Post Your Comments:
(Date:9/30/2014)... (PRWEB) September 30, 2014 Proove ... medicine, is excited to announce a new genetic test ... The Proove Pain Perception Test will provide physicians ... and why pain tolerance levels are stratified between individuals. ... identify whether a person has a genetic predisposition that ...
(Date:9/30/2014)... 30, 2014  RegeneRx Biopharmaceuticals, Inc. (OTC: RGRX) ... has received a Canadian Patent for Inhibition or ... patent includes claims using thymosin beta 4, various ... for these purposes.  The patent will expire in ... ( ) RegeneRx is ...
(Date:9/30/2014)... Hungary , September 30, 2014 ... and intuitive browsing of chemistry in documents ... chemistry software solutions and consulting services for life ... chemical information and generate Markush structures from documents. ... an organizations intellectual property, however generating and understanding ...
(Date:9/30/2014)... 30, 2014 OriginOil Inc. (OTC/QB: OOIL), ... process to clean up large quantities of water, announced ... Eckelberry reported on the launch of the company's CLEAN-FRACâ„¢ ... provided by partner STW Resources . , Immediately ... per day (bpd) and achieved a 99.8% reduction in ...
Breaking Biology Technology:Proove Biosciences is Now Offering the Proove Pain Perception Genetic Test to Help Physicians Assess Patient Pain Tolerance Levels 2Proove Biosciences is Now Offering the Proove Pain Perception Genetic Test to Help Physicians Assess Patient Pain Tolerance Levels 3RegeneRx Receives Canadian Patent for Inhibition or Reversal of Skin Aging 2ChemAxon Introduces ChemCurator for Chemical Information Extraction and Markush Structure Creation 2OriginOil, Inc. Report to Shareholders: Blue Gold in West Texas 2
... GPRO ) announced today that the Company will ... September 24, 2008 at noon,Eastern Time. The presentation is ... a link on the investors section of Gen-Probe,s website ... 30 days,following the event., About Gen-Probe, Gen-Probe ...
... ... FRAZER, Pa., Sept. 19 Cephalon, Inc.,(Nasdaq: CEPH ) has scheduled its regular quarterly earnings ... ... Q3 2008 results will be distributed by PRNewswire, 4:50 p.m. EDT To ...
... PLC Systems Inc.,(Amex: PLC ) today announced that ... qualifications dated September 17, 2008 from the Listing,Qualifications Department ... the Company was not in compliance with Section 1003(a)(ii) ... was less,than $4,000,000 as of June 30, 2008, and ...
Cached Biology Technology:Gen-Probe to Webcast Presentation at the UBS Global Life Sciences Conference 2PLC Systems Receives Delisting Notice From American Stock Exchange 2
(Date:9/30/2014)... research, involving mice and published in the October 2014 ... , suggests that just because you can do ... team of Italian scientists have found that using marijuana ... immune system. This damage may result in autoimmune diseases ... bowel disease and rheumatoid arthritis in adulthood. , "I ...
(Date:9/30/2014)... some hope: A new research report published in October ... , explains how scientists developed a synthetic version of ... development in human and mouse eggs similar to the ... during fertilization. , "We believe that the results of ... understanding of human fertilization by providing a precise answer ...
(Date:9/30/2014)... face a suite of perilous threats in today,s ... and climate change, fragile coral ecosystems are disappearing ... trend, some species of corals surrounding the island ... protector in their tropical environment: coral guard-crabs. New ... Smithsonian Marine Station scientist Seabird McKeon and the ...
Breaking Biology News(10 mins):Adolescent exposure to thc may cause immune systems to go up in smoke 2Synthetic sperm protein raises the chance for successful in vitro fertilization 2Smithsonian scientists discover coral's best defender against an army of sea stars 2
... of Maryland School of Medicine has received a $7.9 million ... Resonance (NMR) magnet that will help researchers unravel the mysteries ... and other diseases. The grant is among the largest of ... Resources (NCRR), which is part of the National Institutes of ...
... of Texas at Dallas researcher and a university-affiliated biomedical ... a long-term cure for tinnitus. Described as a ... 40 percent of recently returned military veterans and about ... The U.S. Veterans Administration spends about $1 billion a ...
... haze hovering over Houston as a result of chemical pollution ... bit thinner, according to a new study. But ... around the world -- come with a catch, says a ... Environmental Sciences, or CIRES, a joint institute of the University ...
Cached Biology News:University of Maryland School of Medicine receives $7.9 million grant for 'super' research magnet 2Tinnitus study looks for cure to 'ringing in the ears' 2Tinnitus study looks for cure to 'ringing in the ears' 3Texas petrochemical emissions down, but still underestimated, says study 2
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Applications: Epitope mapping, Mapping protein-protein contacts, Identification of enzyme substrates/inhibitors, Identification of receptor agonists/antagonists...
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
... Quality ISO 9001:2000 Certified ... All Precedures Validated, SOP's Training ... Process for All Procedures GLP Documentation Upon ... one stop shopping point for all your ...
Biology Products: